Cite
2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry.
MLA
Bruder, O., et al. “2015 Update on Acute Adverse Reactions to Gadolinium Based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry.” Journal of Cardiovascular Magnetic Resonance (Elsevier B.V. ), vol. 17, no. 1, July 2015, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s12968-015-0168-3.
APA
Bruder, O., Schneider, S., Pilz, G., van Rossum, A. C., Schwitter, J., Nothnagel, D., Lombardi, M., Buss, S., Wagner, A., Petersen, S., Greulich, S., Jensen, C., Nagel, E., Sechtem, U., & Mahrholdt, H. (2015). 2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry. Journal of Cardiovascular Magnetic Resonance (Elsevier B.V. ), 17(1), 1–7. https://doi.org/10.1186/s12968-015-0168-3
Chicago
Bruder, O., S. Schneider, G. Pilz, A. C. van Rossum, J. Schwitter, D. Nothnagel, M. Lombardi, et al. 2015. “2015 Update on Acute Adverse Reactions to Gadolinium Based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry.” Journal of Cardiovascular Magnetic Resonance (Elsevier B.V. ) 17 (1): 1–7. doi:10.1186/s12968-015-0168-3.